Drug Information Association Logo
Corporate Tagline

Missing Data: Case Study Presentation & Panel Discussion

Day & Time:
April 29, 3:30PM - 5:00PM

Type:
Session

Title:
Missing Data: Case Study Presentation & Panel Discussion

Chair(s):
Jose C. Pinheiro, PhD
Senior Director, Quantitative Decision Strategies
Janssen Research & Development, LLC, United States

John Scott, PhD
Acting Deputy Director, Division of Biostatistics, OBE, CBER
FDA, United States

Description:
In the second session, a case study in the collection of outcomes data after study drug termination will be presented, followed by a panel discussion involving the case study presenter, a discussant, and the three speakers from the previous session

Presentation(s) & Speaker(s):
Case Study Presenter
Rajeshwari Sridhara, PhD
Director, Division of Biometric V, Office of Biostatistics, OTS, CDER
FDA, United States

Panelist
Thomas J. Permutt, PhD
Director, Division of Biometrics II, CDER
FDA, United States

Panelist
Craig H. Mallinckrodt, PhD
Research Fellow and Technical Lead
Eli Lilly and Company, United States

Panelist
Gary G. Koch, PhD,MS
Director
University of North Carolina at Chapel Hill, United States

Panelist
Jay P. Siegel, MD
Chief Biotechnology Officer, Head Global Regulatory Affairs
Janssen Pharmaceutical R & D (Johnson & Johnson), United States

© 2013 DIA